BIG3 Inhibits the Estrogen-Dependent Nuclear Translocation of PHB2 via Multiple Karyopherin-Alpha Proteins in Breast Cancer Cells
Open Access
- 8 June 2015
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 10 (6) , e0127707
Abstract
We recently reported that brefeldin A-inhibited guanine nucleotide-exchange protein 3 (BIG3) binds Prohibitin 2 (PHB2) in cytoplasm, thereby causing a loss of function of the PHB2 tumor suppressor in the nuclei of breast cancer cells. However, little is known regarding the mechanism by which BIG3 inhibits the nuclear translocation of PHB2 into breast cancer cells. Here, we report that BIG3 blocks the estrogen (E2)-dependent nuclear import of PHB2 via the karyopherin alpha (KPNA) family in breast cancer cells. We found that overexpressed PHB2 interacted with KPNA1, KPNA5, and KPNA6, thereby leading to the E2-dependent translocation of PHB2 into the nuclei of breast cancer cells. More importantly, knockdown of each endogenous KPNA by siRNA caused a significant inhibition of E2-dependent translocation of PHB2 in BIG3-depleted breast cancer cells, thereby enhancing activation of estrogen receptor alpha (ERα). These data indicated that BIG3 may block the KPNAs (KPNA1, KPNA5, and KPNA6) binding region(s) of PHB2, thereby leading to inhibition of KPNAs-mediated PHB2 nuclear translocation in the presence of E2 in breast cancer cells. Understanding this regulation of PHB2 nuclear import may provide therapeutic strategies for controlling E2/ERα signals in breast cancer cells.Keywords
This publication has 28 references indexed in Scilit:
- Elevated expression of protein regulator of cytokinesis 1, involved in the growth of breast cancer cellsCancer Science, 2006
- Mitochondrial Functions and Estrogen Receptor-dependent Nuclear Translocation of Pleiotropic Human Prohibitin 2Journal of Biological Chemistry, 2006
- PDZ-Binding Kinase/T-LAK Cell-Originated Protein Kinase, a Putative Cancer/Testis Antigen with an Oncogenic Activity in Breast CancerCancer Research, 2006
- The Prohibitins: emerging roles in diverse functionsJournal of Cellular and Molecular Medicine, 2006
- Prohibitin: a potential target for new therapeuticsTrends in Molecular Medicine, 2005
- Transcriptional Regulation by the Repressor of Estrogen Receptor Activity via Recruitment of Histone DeacetylasesJournal of Biological Chemistry, 2004
- Analysis of Estrogen Receptor Interaction with a Repressor of Estrogen Receptor Activity (REA) and the Regulation of Estrogen Receptor Transcriptional Activity by REAJournal of Biological Chemistry, 2000
- Evidence for Distinct Substrate Specificities of Importin α Family Members in Nuclear Protein ImportMolecular and Cellular Biology, 1999
- An estrogen receptor-selective coregulator that potentiates the effectiveness of antiestrogens and represses the activity of estrogensProceedings of the National Academy of Sciences, 1999
- A new human breast cancer cell line, KPL-3C, secretes parathyroid hormone-related protein and produces tumours associated with microcalcifications in nude miceBritish Journal of Cancer, 1996